FDA Issues Emergency Approval For Coronavirus Treatment Drug
President Donald Trump and the Food and Drug Administration announced Friday that it has approved the experimental drug remdesivir for treating coronavirus patients who require hospitalization.
The drug is administered intravenously once a day for up to 10 days and is believed to help patients recover faster.
Its manufacturer, Gilead Sciences, plans to donate 1.1 million vials of the drug and will work with the federal government to distribute it, Gilead CEO Daniel O’Day said at the White House on Friday.
Dr. Anthony Fauci, the nation’s leading official on infectious diseases, had touted an international study of more than 1,000 people earlier this week that supported the drug’s use. An independent data monitoring board that works with the National Institute of Allergy and Infectious Diseases, which Fauci leads, determined that the drug was effective.
[Source: Huffington Post]